(Press-News.org) It's a common dilemma faced by many working parents: your child has a cough or a cold, do you send them to nursery?
Researchers from the University of Bristol have, for the first time, investigated the process of decision-making that parents go through when faced with this situation. The research, published in The Journal of Public Health, reports that parents viewed coughs and colds as less serious and not as contagious as sickness and diarrhoea symptoms.
This resulted in many parents sending their child to daycare with a respiratory tract infection (RTI), which can result in the spread of similar illnesses in the wider community.
The Parents' Choices About Daycare (PiCArD) study team, funded by the NIHR School for Primary Care Research (SPCR), interviewed 31 parents about the decisions they make when their children are unwell. The researchers explored parents' attitudes towards illness, what they currently do if their child is unwell and due to attend nursery, as well as any changes that could affect the decisions they make.
Dr Fran Carroll, Research Associate in the University of Bristol's Centre for Academic Primary Care and lead author of the study, said: "Parents are aware that sending their child to nursery when they are unwell is not always the ideal thing to do, but there are often other factors meaning it is not possible to keep their child at home.
"However, there are some changes that nurseries could make which may help parents with their decisions and reduce the spread of infectious illnesses in both children and staff in nursery environments."
Although some parents were aware of the content of the nursery sickness policies, they often felt the guidance was less clear on respiratory symptoms than for sickness and diarrhoea, or chicken pox, for example.
The research found that parents made decisions not only based on what the nursery illness policy was, but also on practical issues such as missing time from work, financial consequences, and the availability of alternative care.
Parents also named some nursery factors that could be changed to help them keep unwell children at home.
These included a reduction in nursery fees if the child cannot attend, being able to swap sessions, and clearer guidance in nursery sickness policies.
The researchers hope that their work will inform the design and implementation of interventions to reduce the transmission of infectious illness and the associated burden on NHS services.
"Our findings may not be news to many parents, but this is the first time their decision-making processes in these situations has been documented," said Dr Carroll. "By having this work published in a peer-reviewed journal, it gives an academic, methodologically sound basis for future work and interventions to try and reduce the spread of illnesses in these settings."
INFORMATION:
Further information
Paper: External pressures increase parents' thresholds for sending children with respiratory tract infections to nursery, Fran Carroll, Leila Rooshenas, Hareth Al-Janabi, Amanda Owen-Smith, Sandra Hollinghurst, Alastair Hay.
In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research (ISSCR) has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications. The research article, entitled "CRISPR/Cas9-mediated Gene Editing in Human Tripronuclear Zygotes," was published online on April 18 in the scientific ...
Imagine a day when scientists are able to alter the DNA of organisms in the lab in the search for answers to a host of questions. Or imagine a day when doctors treat genetic disorders by administering drugs designed to alter a patient's genome.
It may sound like science fiction, but with the development of genome-editing proteins like Cas9 and CRISPR, it could one day become science fact.
Before that happens, however, scientists must overcome a number of challenges, including how to improve the specificity of these proteins- the rate at which genome-editing proteins ...
A more intellectually demanding job may be the key to living longer after developing young-onset dementia, according to health researchers.
Degeneration of the frontal and temporal parts of the brain leads to a common form of dementia affecting people under the age of 65. It results in changes in personality and behavior and problems with language, but does not affect memory.
"[Our] study suggests that having a higher occupational level protects the brain from some of the effects of this disease, allowing people to live longer after developing the disease," said Lauren ...
An international team of scientists is calling for urgent and temperature patterns in mountain regions after compiling evidence that high elevations could be warming faster than previously thought.
Without substantially better information, people risk underestimating the severity of a number of already looming environmental challenges, including water shortages and the possible extinction of some alpine flora and fauna, according to the research team, which includes Henry Diaz and Imtiaz Rangwala from CIRES, the Cooperative Institute for Research in Environmental Sciences ...
Shetland ponies' immune response to insect bites is helping scientists understand how people could be prevented from developing allergies.
The horse immune system can respond to midge bites in a way that prevents - rather than triggers - allergic reactions, researchers say.
The ponies' immune response to midge bites is similar to what happens in people with allergies, the team says. Understanding what triggers allergic reactions could help researchers come up with ways to stop people developing sensitivities.
It was previously thought that ponies which do not suffer ...
April 23, 2015, Vienna, Austria: A drug approved to treat type 2 diabetes could prove to be a powerful new treatment option for non-alcoholic steatohepatitis (NASH), according to research presented today at The International Liver CongressTM 2015. Results from a randomised controlled trial showed liraglutide met the primary endpoint of histological clearance of NASH, and a reduction in the progression of fibrosis. The research was supported by the Wellcome Trust and the NIHR.
In the Liraglutide Efficacy and Action in NASH (LEAN) trial, overweight patients with biopsy-confirmed ...
April 23, 2015, Vienna, Austria: Phase III results revealed today at The International Liver Congress™ 2015 show that once-daily treatment with daclatasvir (DCV) plus sofosbuvir (SOF) resulted in an overall 97% sustained virologic response (SVR) at 12 weeks post-treatment in patients with hepatitis C virus (HCV) and HIV co-infection, including cirrhotic patients.
HIV co-infection more than triples the risk of hepatitis C-related liver disease, liver failure and liver-related death. Co-infection can also complicate the management of HIV infection.
In the ALLY-2 ...
April 23, 2015, Vienna, Austria: A new study presented today at The International Liver Congress™ 2015 shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma (HCC), it is possible to identify specific molecular profiles. It is hoped that these molecular profiles will help identify which patients would benefit from specific anticancer treatments.
Using exome sequencing - a technique for sequencing all the protein-coding genes in a genome - the study identified relationships between environmental ...
April 23, 2015, Vienna, Austria: Results presented today at The International Liver Congress™ 2015 show that the use of the fixed-dose combination of ledipasvir/sofosbuvir (LDV/SOF) in combination with ribavirin (RBV) was well tolerated and demonstrated high sustained virologic response rates 12 weeks post treatment (SVR12) in patients with chronic hepatitis C virus (HCV) infection who have decompensated liver disease (cirrhosis) or have undergone liver transplantation.
SOLAR 2 data are presented for 328 HCV genotype-1 or -4 treatment-naive or treatment-experienced ...
April 23, 2015, Vienna, Austria: Results revealed today at The International Liver Congress™ 2015 show that vitamin E (d-alpha-tocopherol) is an effective treatment for non-alcoholic steatohepatitis (NASH). NASH occurs when the liver becomes inflamed due to the accumulation of fat. Over time, persistent inflammation can lead to the formation of fibrous scar tissue in the liver and around its blood vessels, which can eventually cause cirrhosis.
A pooled analysis of data from two randomised trials comparing vitamin E versus placebo, and the placebo group from another ...
